TTD II: Impact of Bacteria Detection of Platelets
Program Code: 124-S
Saturday, October 15, 2005
2:00 PM to 3:30 PM (ET)

MODERATOR
Mark Brecher, MD, University of North Carolina Hospitals

SPEAKERS
Roslyn Yomtovian, MD, Department of Pathology, Case Western Reserve Univ
James P. AuBuchon, MD, Dartmouth-Hitchcock Medical Center
Stein Holme, PhD, PALL Life Sciences

DESCRIPTION
In March 2004, AABB Standard 5.1.5.1 went into effect. This requirement for bacterial quality control has far-ranging implications on patient safety, platelet shelf life and the possibility of pre-storage pooling of whole-blood-derived platelets. Updates on the current state of the art will be presented via lecture and case studies.